Product Description
Overall, the dental soft tissue wound care market was valued at nearly $180 million in 2025. This is expected to increase over the forecast period at a CAGR of 11.8% to nearly $390 million.
The full report suite on the global market for dental soft tissue wound care market includes segments for plug, tape and foam products.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Dental Soft Tissue Wound Care Market Trends
While the dental wound care market is relatively mature compared with regenerative biomaterials, it remains characterized by stable demand and incremental innovation. Adoption is driven primarily by clinical familiarity, ease of use and cost considerations rather than disruptive technological change. As a result, plugs, tapes and foams continue to serve as standard-of-care products across a wide range of dental practices, supporting consistent utilization and steady market growth over the forecast period.
Global Dental Soft Tissue Wound Care Market Share Insights
- ZimVie is the leading competitor in the dental soft tissue wound care market in 2025. The company’s strong position is supported by its well-established portfolio of collagen-based wound care products, including tapes, foams and plugs, which are widely used for hemostasis, wound protection and soft tissue healing following dental extractions, periodontal procedures and other oral surgeries. ZimVie’s dental wound care products are resorbable and designed to stabilize the surgical site, control bleeding and support predictable soft tissue regeneration, making them suitable for routine and complex procedures alike. Integrated within a broader biomaterial offering that includes bone graft substitutes and barrier membranes, ZimVie’s wound care solutions benefit from strong clinician familiarity, broad global distribution and alignment with standardized post-operative dental workflows, reinforcing the company’s leadership in this segment.
- AbbVie is another leading competitor in the global dental soft tissue wound care market in 2025, following its acquisition of Allergan in May 2020. AbbVie’s presence in this segment is anchored by AlloDerm Regenerative Tissue Matrix (RTM), an acellular dermal matrix derived from human tissue and widely used in dental and oral surgery for soft tissue grafting, wound coverage and site management. AlloDerm™ promotes soft tissue regeneration by supporting rapid vascularization, immune cell migration and cellular repopulation, contributing to predictable clinical outcomes. The product has been used in dentistry since the mid-1990s and is supported by one of the largest bodies of long-term, peer-reviewed clinical evidence among dental soft tissue regenerative products. Globally, AlloDerm™ is distributed through regional partners, including BioHorizons in select markets, reinforcing its integration into implant- and periodontal-related procedures. AbbVie’s dental soft tissue portfolio is primarily concentrated in the allograft segment and the company does not currently maintain a broad xenograft offering within dental soft tissue wound care.
- Henry Schein participates in the dental wound care market primarily through its distribution network and affiliated regenerative brands. Through subsidiaries such as BioHorizons and ACE Southern, as well as third-party product distribution, the company supplies a range of collagen wound dressings including collagen plugs, collagen tape and collagen foam used to control bleeding and protect surgical sites after extractions or periodontal procedures. Henry Schein’s broad distribution network enables these wound care products to reach clinicians across multiple global markets.
Global Dental Soft Tissue Wound Care Market Segmentation Summary
- Dental Soft Tissue Wound Care Market – Further Segmented Into:
- Type: Plug, Tape, and Foam.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Region | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
